Current guidelines recommend dual antiplatelet therapy ... MD: Maintenance dose; NSTE-ACS: Non-ST-segment elevation acute coronary syndrome; OPTIMUS: Optimizing Anti-Platelet Therapy in Diabetes ...
Although patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) have been shown to benefit with an early invasive therapy as compared with medical management, especially in high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback